New

Keep tabs on your favorite ETFs with a personalized weekly tracker. Create a Watchlist now →

Advertisement
ETF Central logo
Advertisement

FTXHvsXLVETF Comparison

ETF 1
FTXH

First Trust Nasdaq Pharmaceuticals ETF

This fund is part of
US Health Care
-0.51%
Full FTXH fund page
VS
ETF 2
XLV

State Street Health Care Select Sector SPDR ETF

This fund is part of
US Health Care
-0.51%
Full XLV fund page

First Trust Nasdaq Pharmaceuticals ETF (FTXH) and State Street Health Care Select Sector SPDR ETF (XLV) belong to the same industry segment: US Health Care. Both ETFs have the same top 3 sector exposures: and Health Care. FTXH is more expensive with a Total Expense Ratio (TER) of 0.6%, versus 0.08% for XLV. FTXH is up 5.06% year-to-date (YTD) with +$7M in YTD flows. XLV performs worse with -1.03% YTD performance, and +$1.01B in YTD flows. Run a side-by-side ETF comparison of FTXH and XLV below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.

Find out how industry players manage ETF portfolios.  Discover our library of Model portfolios

FTXH vs XLV performance and flow charts

Performance

-2.0-1.00.01.02.03.0%Feb 10Feb 18Feb 25Mar 4

Cumulative Flows

-800 M-600 M-400 M-200 M0 M200 MFeb 10Feb 18Feb 25Mar 4

Get all the metrics on this page, and more, through a reliable ETF data feed

Daily, global ETF data for advanced analysis or integration into apps (API), from our partner Trackinsight.

Historic performance and flows
Data as of 03/10/2026
1M3MYTD1Y3Y5Y
Perf.
FTXH
XLV
-0.60%-1.40%
+7.47%+1.13%
+5.06%-1.03%
+22.29%+5.51%
+43.33%+29.64%
+43.47%+45.96%
Flows
FTXH
XLV
+$5M-$720M
+$9M+$376M
+$7M+$1.01B
+$10M+$304M
-$13M-$4.79B
+$4M+$7.07B
Volatility and drawdown
3M1Y3Y5Y
Volatility
FTXH
XLV
+15.29%+13.70%
+20.64%+17.44%
+15.87%+13.60%
+15.67%+14.47%
Max drawdown
FTXH
XLV
-4.33%-4.63%
-17.49%-12.44%
-19.32%-17.05%
-19.32%-17.05%
Max drawdown duration
FTXH
XLV
9d9d
203d225d
393d444d
393d444d
Trading data

Create an account to view trading data

Join for free
FTXH
XLV
Last sale
3/11/2026 at 1:30 PM
$34.46
$152.85
Previous close
03/10/2026
$34.57
$153.15
Consolidated volume
03/10/2026
Average volume
30 days
Average discount or premium
30 days
Average Bid/Ask spread
30 days
Replication quality
Data as of February 27, 2026
1-year trailing difference

Create an account to view replication metrics

Join for free

Create an account to view replication quality

Join for free
FTXH
XLV
Tracking error
Tracking difference
1 year cumulative return difference
Best
Worst
Daily return difference
Average
Worst
Advertisement
Main metrics
Last update 3/11/2026 at 1:30 PM
Live
Closed
FTXH
XLV
Last price
$34.46
$152.85
1D performance
-0.33%
-0.20%
AuM$29.41 M$40.26 B
E/R0.6%0.08%
Characteristics
FTXH
XLV
Management strategyPassivePassive
ProviderFirst TrustSPDR
BenchmarkNASDAQ US Smart Pharmaceuticals IndexS&P Health Care Select Sector Index
N° of holdings4957
Asset classEquitiesEquities
Trailing 12m distribution yield
Join
Join
Inception dateSeptember 20, 2016December 16, 1998
ESGNoNo
Advertisement
Exposure

Countries

FTXH
USA
95.63%
Other
4.37%
XLV
USA
96.98%
Other
3.02%

Sectors

FTXH
Health Care
98.8%
Other
1.2%
XLV
Health Care
98.26%
Other
1.74%
Advertisement

Diversification

FTXH

Total weight of top 15 holdings out of 15

71.63%
XLV

Total weight of top 15 holdings out of 15

70.12%

Top 15 holdings

Data as of January 31, 2026
FTXH
MERCK & CO INC
7.83%
JOHNSON&JOHNSON
7.66%
BRISTOL-MYERS SQUIBB
6.97%
PFIZER
6.38%
ABBVIE
6.33%
CARDINAL HEALTH
4.31%
LILLY
4.23%
BIOGEN INC
3.99%
REGENERON PHARMACEUTICALS
3.81%
GILEAD SCIENCES
3.75%
VIATRIS INC
3.71%
VERTEX PHARMACEUTICALS
3.59%
AMGEN-T
3.55%
UTD THERAPEUT
3.14%
ZOETIS INC
2.38%
XLV
LILLY
14.69%
JOHNSON&JOHNSON
9.77%
ABBVIE
7.03%
MERCK & CO INC
4.88%
UNITEDHEALTH GRP
4.64%
THERMO FISHER SCIENTIFIC
3.88%
ABBOTT LABS
3.39%
AMGEN-T
3.28%
INTUITIVE SURGICAL
3.19%
GILEAD SCIENCES
3.14%
PFIZER
2.68%
BOSTON SCIENTIFIC
2.47%
DANAHER
2.45%
MEDTRONIC PLC
2.36%
STRYKER
2.27%
Frequently asked questions about FTXH and XLV

How have the FTXH and XLV ETFs performed in 2026?

As of March 10, 2026, FTXH is up 5.06% year-to-date (YTD), while XLV has lost -1.03%. That puts FTXH better performer ahead so far this year.

Which ETF is attracting more investor money: FTXH or XLV?

Year-to-date, the FTXH ETF saw +$7M in flows, compared to +$1.01B for XLV.

Which ETF is more volatile: FTXH or XLV?

Over the past year, FTXH had a volatility of 20.64%, while XLV experienced 17.44%.

Which ETF is bigger: FTXH or XLV?

As of March 10, 2026, FTXH holds $29.41 M in assets under management (AUM), while XLV manages $40.26 B.

What sectors do the FTXH and XLV ETFs invest in?

FTXH leans toward sectors like Health Care. Meanwhile, XLV focuses on Health Care.

What are the top holdings of the FTXH ETF and XLV ETF?

FTXH top holdings include MERCK & CO INC, JOHNSON&JOHNSON and BRISTOL-MYERS SQUIBB. XLV holds in its top three: LILLY, JOHNSON&JOHNSON and ABBVIE.

Which ETF is more diversified: FTXH or XLV?

FTXH holds 50 securities with 71.63% of its assets in the top 15. XLV has 60 securities and a top 15 weight of 70.12%.

Advertisement
Advertisement
Advertisement
The Active Trader Report

Active Trader Report: Use of Leveraged & Inverse ETFs Way Up

Direxion partnered with Compound Insights and Vanda to explore what’s driving the evolution of active trading — and how active traders are using leveraged and inverse funds across equities, single stocks, commodities, and volatility.

Active Trader Report: Use of Leveraged & Inverse ETFs Way Up